Envelope glycoprotein GP350

BE0000594ProteinHHV-4

Initiates virion attachment to host B-lymphocyte cell, leading to virus entry. It is acted on by 1 drug in DrugBank.

UniProtKB entry
P03200Swiss-Prot
Cellular location
Virion membrane
Residues / weight
907 residues · 94,431 Da
Also known as
MA · Membrane antigen

Resolves to

Protein
UniProtP03200UniProt nameGP350_EBVB9
Gene
NCBI Gene3783713GenBank1334868
Pharmacology
KEGGvg:3783713
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Envelope glycoprotein GP350, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In